The WHO indicates that several claim applications have been made under the COVAX no-fault lump-sum compensation program for COVID-19 vaccines. It remains to be seen how the scheme may apply to countries like India, which is also expected to take a call on indemnity to vaccine makers.
Claim applications pertaining to COVID-19 vaccines have begun flowing in under the World Health Organization-backed COVAX facility no-fault compensation program, the global health agency has confirmed to Scrip.
The vaccine injury compensation mechanism was operationalized at the end of March this year and the “administrator has received a number of applications to date” the WHO said
AbbVie chief commercial officer Jeffrey Stewart called Trump’s drug pricing plan a “disruption” but said ultimately the delta between US and EU drug prices may not be as high as some expect.
At the Bank of America health care conference, pharma leaders speculated on what Trump’s executive order on drug pricing could mean for US and European drug prices.
The acquisition of Boston Pharma’s once-a-month FGF21 analog adds to GSK’s liver disease portfolio.
